Anticoagulation therapy: Long-term dabigatran therapy reduces the risk of recurrent venous thromboembolism
- PMID: 23478258
- DOI: 10.1038/nrcardio.2013.33
Anticoagulation therapy: Long-term dabigatran therapy reduces the risk of recurrent venous thromboembolism
Comment on
-
Extended use of dabigatran, warfarin, or placebo in venous thromboembolism.N Engl J Med. 2013 Feb 21;368(8):709-18. doi: 10.1056/NEJMoa1113697. N Engl J Med. 2013. PMID: 23425163 Clinical Trial.
References
-
- N Engl J Med. 2013 Feb 21;368(8):709-18 - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
